Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00118
|
|||||
| Drug Name |
Sphingosine-1-phosphate
|
|||||
| Synonyms |
(2S,3R,4E)-2-Amino-4-octadecene-1,3-diol 1-(Dihydroge; (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate; 26993-30-6; 4-Octadecene-1,3-diol, 2-amino-, 1-(dihydrogen phosphate), (2S,3R,4E)-; C18-Sphingosine 1-phosphate; CHEBI:37550; CHEMBL225155; D-erythro-Sphingosine-1-phosphate; D-erythro-sphingosine 1-phosphate; DUYSYHSSBDVJSM-KRWOKUGFSA-N; S1P; Sphing-4-enine 1-phosphate; Sphing-4-enine-1-phosphate; Sphingosine 1-phosphate; Sphingosine 1-phosphic acid; UNII-YVE187NJ1U; YVE187NJ1U; sphingosine-1-phosphate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Acne vulgaris [ICD11: ED80] | Phase 1 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C18H38NO5P
|
|||||
| Canonical SMILES |
CCCCCCCCCCCCCC=CC(C(COP(=O)(O)O)N)O
|
|||||
| InChI |
InChI=1S/C18H38NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h14-15,17-18,20H,2-13,16,19H2,1H3,(H2,21,22,23)/b15-14+/t17-,18+/m0/s1
|
|||||
| InChIKey |
DUYSYHSSBDVJSM-KRWOKUGFSA-N
|
|||||
| CAS Number |
CAS 26993-30-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 379.5 | Topological Polar Surface Area | 113 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 17 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
1.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103513044
, 104045126
, 104046551
, 11039024
, 112629138
, 113860431
, 11538026
, 123055038
, 135061792
, 135651563
, 137123351
, 141225271
, 144107094
, 14853517
, 14902393
, 162223883
, 163687305
, 164808502
, 175443701
, 179205494
, 226395983
, 228659508
, 241182370
, 241375387
, 24893757
, 24899853
, 250135272
, 252467313
, 26754964
, 26754965
, 26759550
, 29214822
, 3153153
, 39316963
, 4266347
, 47736194
, 50069271
, 53790239
, 56310719
, 56314086
, 56314115
, 57358934
, 79196702
, 8381
, 841938
, 85230694
, 91616005
, 99431555
|
|||||
| ChEBI ID |
CHEBI:37550
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [3] | ||
| SPNS2 | Transporter Info | Protein spinster homolog 2 | Substrate | [4] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01466322) A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. | |||||
| 2 | Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem. 2010 Apr 2;285(14):10477-86. | |||||
| 3 | Lipid dependence of ABC transporter localization and function. Chem Phys Lipids. 2009 Oct;161(2):57-64. | |||||
| 4 | The ABCs of membrane transporters in health and disease (SLC series): Introduction. Molecular Aspects of Medicine, 2013, 34(2-3):95-107. (GeneName=SLC63A2) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.